Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
Current Opinion in Infectious Diseases
|
October 25, 2013
Pharmacological considerations on the use of antiretrovirals in pregnancy
Angela Colbers, Rick Greupink, David Burger
British Journal of Clinical Pharmacology
|
October 7, 2017
Free dug concentrations in pregnancy: Bound to measure unbound?
Stein Schalkwijk, Rick Greupink, David Burger
CPT: Pharmacometrics & Systems Pharmacology
|
January 20, 2018
Drug Dosing in Pregnant Women: Challenges and Opportunities in Using Physiologically Based Pharmacokinetic Modeling and Simulations
Alice Ban Ke, Rick Greupink, Khaled Abduljalil
CPT: Pharmacometrics & Systems Pharmacology
|
January 19, 2026
Validating Physiologically-Based Pharmacokinetic Models Using the Continuous Ranked Probability Score: Beyond Being Correct on Average
Laurens Sluijterman, Marjolein van Borselen, Rick Greupink, et al.
Pharmaceutical Research
|
September 26, 2009
Evaluation of a 99mTc-labeled AnnexinA5 variant for non-invasive SPECT imaging of cell death in liver, spleen and prostate
Rick Greupink, Charles F Sio, Antwan Ederveen, et al.
British Journal of Clinical Pharmacology
|
November 7, 2025
Physiologically based pharmacokinetic model combined with a clinical lactation study to determine doravirine concentrations in human breastmilk
Lena van der Wekken-Pas, David Burger, Rick Greupink, et al.
Journal of the International AIDS Society
|
July 19, 2022
Non-clinical considerations for supporting accelerated inclusion of pregnant women in pre-licensure clinical trials with anti-HIV agents
Rick Greupink, Hedwig van Hove, Felix Mhlanga, et al.
Clinical Pharmacokinetics
|
September 16, 2015
Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy
Angela Colbers, Rick Greupink, Carlijn Litjens, et al.
American Journal of Obstetrics and Gynecology
|
July 31, 2024
Physiologically based pharmacokinetic modeling to guide dose optimization in obstetrical pharmacology clinical trials: a response
Joyce E M van der Heijden, Saskia N de Wildt, Rick Greupink
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
September 12, 2022
Predicting fetal exposure of crizotinib during pregnancy: Combining human ex vivo placenta perfusion data with physiologically-based pharmacokinetic modeling
Damian Roelofsen, Hedwig van Hove, Vera Bukkems, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
Current Opinion in Infectious Diseases
|
October 25, 2013
Pharmacological considerations on the use of antiretrovirals in pregnancy
Angela Colbers, Rick Greupink, David Burger
British Journal of Clinical Pharmacology
|
October 7, 2017
Free dug concentrations in pregnancy: Bound to measure unbound?
Stein Schalkwijk, Rick Greupink, David Burger
CPT: Pharmacometrics & Systems Pharmacology
|
January 20, 2018
Drug Dosing in Pregnant Women: Challenges and Opportunities in Using Physiologically Based Pharmacokinetic Modeling and Simulations
Alice Ban Ke, Rick Greupink, Khaled Abduljalil
CPT: Pharmacometrics & Systems Pharmacology
|
January 19, 2026
Validating Physiologically-Based Pharmacokinetic Models Using the Continuous Ranked Probability Score: Beyond Being Correct on Average
Laurens Sluijterman, Marjolein van Borselen, Rick Greupink, et al.
Pharmaceutical Research
|
September 26, 2009
Evaluation of a 99mTc-labeled AnnexinA5 variant for non-invasive SPECT imaging of cell death in liver, spleen and prostate
Rick Greupink, Charles F Sio, Antwan Ederveen, et al.
British Journal of Clinical Pharmacology
|
November 7, 2025
Physiologically based pharmacokinetic model combined with a clinical lactation study to determine doravirine concentrations in human breastmilk
Lena van der Wekken-Pas, David Burger, Rick Greupink, et al.
Journal of the International AIDS Society
|
July 19, 2022
Non-clinical considerations for supporting accelerated inclusion of pregnant women in pre-licensure clinical trials with anti-HIV agents
Rick Greupink, Hedwig van Hove, Felix Mhlanga, et al.
Clinical Pharmacokinetics
|
September 16, 2015
Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy
Angela Colbers, Rick Greupink, Carlijn Litjens, et al.
American Journal of Obstetrics and Gynecology
|
July 31, 2024
Physiologically based pharmacokinetic modeling to guide dose optimization in obstetrical pharmacology clinical trials: a response
Joyce E M van der Heijden, Saskia N de Wildt, Rick Greupink
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
September 12, 2022
Predicting fetal exposure of crizotinib during pregnancy: Combining human ex vivo placenta perfusion data with physiologically-based pharmacokinetic modeling
Damian Roelofsen, Hedwig van Hove, Vera Bukkems, et al.
Page
of 8